Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development

Oncology drug development is among the most challenging of any therapeutic area, with first‐in‐human trials expected to deliver information on both safety and activity. Until recently, therapeutic approaches in oncology focused on cytotoxic chemotherapy agents, ruling out even the possibility of enr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Mariam A., Patel, Chirag, Drezner, Nicole, Helms, Whitney, Tan, Weiwei, Stypinski, Daria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951451/
https://www.ncbi.nlm.nih.gov/pubmed/31674150
http://dx.doi.org/10.1111/cts.12703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951451/
https://www.ncbi.nlm.nih.gov/pubmed/31674150
http://dx.doi.org/10.1111/cts.12703

Ejemplares similares